Physician profile
Isaac Felemovicius
NPI 1881649291
$179,839.81
in general payments reported to CMS, 2019-2025
7 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.90 · 2020: $1,480 · 2021: $35K · 2022: $20K · 2023: $23K · 2024: $22K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $3,857 · Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,299.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,700.00 |
| Travel and Lodging | $3,857.43 |
| Food and Beverage | $505.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $100,158.64 | 2021-2025 | Echelon Circular, Echelon Endopath, Echelon Flex |
| Ethicon Endo-Surgery INC. | $50,700.00 | 2025 | |
| Ethicon US, LLC | $27,380.24 | 2021-2025 | Echelon Circular, Enseal X1, Echelon; Endopath |
| Gyrus Acmi, INC. | $1,155.00 | 2020 | |
| Covidien LP | $325.00 | 2020 | |
| Intuitive Surgical, INC. | $88.03 | 2023 | Da Vinci Surgical System |
| Davol INC. | $32.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Felemovicius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.